Search

everythinglearnresearchcommunity

for

Search:↓

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Check and treat low iron and vitamin D levels in people with hair loss.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

More research is needed to determine if iron deficiency causes hair loss.

Scientists have made progress in growing mini-organs and regenerating parts of the skin, with plans to treat hair loss in a future trial.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Updated treatments for female hair loss include minoxidil, antiandrogens, hair transplants, and light therapy.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

The workshop highlighted the genetic links and psychological impacts of hair loss and skin disorders.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The GH-IGF-I axis is likely involved in the hormonal imbalances seen in non-obese women with functional hyperandrogenism.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.